46461 - Wholesale of medicines and other pharmacy goods 46211 - Wholesale of grain, unmanufactured tobacco, seeds and animal feeds 74901 - Other professional, scientific and technical activities n.e.c.

Revenue

Profit

Profit margin

Gross salary

Equity

Employees

Annual report

Tax arrears

No tax arrears

Return on equity

Return on assets

Related parties

	Owner	Representative	Beneficial owner	Roles
Dimedium Group OÜ 10003040	100% - 144 000.00 EUR	-	-	Shareholder
Merje Rosen	-	Board member	-
Neidi Puur	-	Board member	-
Sivar Irval	-	Board member	-
Kadri Kullman	-	-	-	Board member
Mirjam Irval	-	-	-	Board member
Oliver Kullman	-	-	-	Chairman of the board

Paid taxes, taxable turnover and number of employees

	Turnover	State taxes	Labor taxes and payments	Employees
2024 Q4	4 998 368.59 €	632 910.76 €	162 552.55 €	34
2024 Q3	6 488 841.25 €	761 884.82 €	157 731.02 €	37
2024 Q2	5 600 263.01 €	710 459.01 €	142 254.59 €	35
2024 Q1	4 608 299.29 €	583 973.53 €	148 751.46 €	35
2023 Q4	5 539 369.7 €	586 496.66 €	136 471.09 €	32
2023 Q3	5 620 272.99 €	683 393.04 €	151 722.04 €	30
2023 Q2	5 799 645.74 €	647 547.35 €	149 913.98 €	33
2023 Q1	5 237 792.5 €	626 795.06 €	155 966.26 €	32
2022 Q4	5 397 737.75 €	605 550.15 €	145 883.22 €	30
2022 Q3	5 914 380.74 €	631 463.57 €	146 545.4 €	29
2022 Q2	6 176 074.59 €	691 563.21 €	138 726.63 €	29
2022 Q1	4 436 583.6 €	501 862.96 €	138 519.44 €	30
2021 Q4	4 387 078.9 €	483 817.93 €	123 941.74 €	29
2021 Q3	4 586 316.72 €	519 146.42 €	131 397.88 €	29
2021 Q2	4 632 237.63 €	492 326.25 €	131 297.53 €	30
2021 Q1	4 071 590.16 €	493 116.71 €	149 285.06 €	33
2020 Q4	4 212 641.08 €	486 152.95 €	119 343.59 €	35
2020 Q3	4 036 996.22 €	445 857.92 €	126 135.41 €	33
2020 Q2	4 132 987.88 €	451 264.74 €	121 111.42 €	31
2020 Q1	3 612 985.8 €	421 441.89 €	130 933.29 €	31